# Nurix Therapeutics (NRIX): Sanofi's Decision to Discontinue Development, a 38.2% Drop

> Source: IndicatorStack, https://indicatorstack.com/catalysts/nrix-2026-11-04-release. Updated Nov 19, 2026, 7:25 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3, and the stock went from Tuesday’s $25.82 close to as low as $14.78. It finished the session −38.2% at $15.95 on 6.9 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 3:56 AM ET. NASDAQ: NRIX, Biotechnology. All times ET.

## The numbers

- −38.2% Wednesday’s close ($25.82 to $15.95, low $14.78)
- 6.9× its 20-day average volume (19.6M shares on the day)
- 4:01 PM the catalyst crossed, ET (Tuesday, after the close)
- 104M float, shares (19% of the float traded on Wednesday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Tue close | $25.84 | Bearish, weakening | Leaning down |
| Into the open | Wed 9:30 AM | $17.15 | Bearish, strong | Tailwind down |
| 30 minutes in | Wed 10:00 AM | $15.48 | Bearish, strong | Tailwind down |
| At the close | Wed 4:00 PM | $15.95 | Neutral | Tailwind down |
| Thursday’s close | Thu 4:00 PM | $14.81 | Bearish, strong | Tailwind down |
| Friday’s close | Fri 4:00 PM | $15.29 | Bearish, weakening | Tailwind down |
| Monday’s close | Mon 4:00 PM | $16.13 | Neutral | Tailwind down |

## Timeline

### Tuesday, November 3

- 4:01 PM: Sanofi's decision to discontinue development of STAT6 degrader SAR448272 (Press release, GlobeNewsWire)
- 4:02 PM: Current report (Form 8-K) filed (Accepted by the SEC at 4:02:18 PM ET)

### Wednesday, November 4

- 4:40 AM: Premarket high $19.01 (−26.4% from the prior close)
- 7:15 AM: 5-minute stack bias turned bearish (at $17.23)
- 9:25 AM: Trigger marked a short at $17.15 (Hypothetical, default settings: reached $16.13 at 9:40 AM for +2.8R (target))
- 9:30 AM: Opened at $17.16 (−33.5% from Tuesday’s $25.82 close)
- 10:25 AM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $15.01)
- 10:45 AM: Session low $14.78
- 12:25 PM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $15.32)
- 1:15 PM: 5-minute stack bias turned bullish (at $15.48)
- 3:50 PM: 5-minute stack bias went neutral (at $15.69, its inputs no longer agreeing)
- 4:00 PM: Closed at $15.95, −38.2% on the day (19.6M shares, 6.9× its 20-day average)

### Thursday, November 5

- 7:00 AM: To Present new and updated data from ongoing Phase 1a/1b trial of bexobrutideg (Press release, GlobeNewsWire)
- 7:30 AM: 5-minute stack bias turned bearish (at $15.91)
- 9:30 AM: Opened at $16.01 (+0.4% from Wednesday’s $15.95 close)
- 10:20 AM: Session high $16.59
- 10:20 AM: 5-minute stack bias turned bullish (at $16.54)
- 10:55 AM: 5-minute stack bias went neutral (at $15.91, its inputs no longer agreeing)
- 11:10 AM: 5-minute stack bias turned bearish (at $15.97)
- 11:25 AM: 5-minute stack bias went neutral (at $16.15, its inputs no longer agreeing)
- 11:35 AM: 5-minute stack bias turned bullish (at $16.11)
- 12:10 PM: 5-minute stack bias went neutral (at $15.98, its inputs no longer agreeing)
- 12:15 PM: 5-minute stack bias turned bearish (at $15.98)
- 1:22 PM: Amended ownership stake (Schedule 13G/A) filed (Accepted by the SEC at 1:22:27 PM ET)
- 3:55 PM: Session low $14.80
- 4:00 PM: Closed at $14.84, −7.0% on the day (7.1M shares, 1.9× its 20-day average)

### Friday, November 6

- 9:30 AM: Opened at $15.10 (+1.8% from Thursday’s $14.84 close)
- 9:40 AM: Session low $14.79
- 10:30 AM: 5-minute stack bias turned bullish (at $15.32)
- 11:55 AM: Session high $15.52
- 2:05 PM: 5-minute stack bias went neutral (at $15.23, its inputs no longer agreeing)
- 2:15 PM: 5-minute stack bias turned bearish (at $15.19)
- 4:00 PM: Closed at $15.30, +3.1% on the day (3M shares, 0.7× its 20-day average)

### Monday, November 9

- 7:10 AM: 5-minute stack bias turned bullish (at $15.31)
- 9:30 AM: Opened at $15.32 (+0.1% from Friday’s $15.30 close)
- 9:40 AM: Session low $15.27
- 1:30 PM: Session high $16.63
- 3:55 PM: 5-minute stack bias went neutral (at $16.13, its inputs no longer agreeing)
- 4:00 PM: Closed at $16.14, +5.5% on the day (7.6M shares, 1.9× its 20-day average)

## Before the catalyst (Tuesday, November 3)

Nurix Therapeutics closed Tuesday at $25.82. The 5-minute stack bias was bearish (weakening), since 12:45 PM: under VWAP 26.04 and a falling SMA, momentum down and trend strength with the sellers. Compass read “Leaning down” (15m ↘ 1h ↘ 2h ↘ 4h ↗ D ↗). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Clean, nothing major in the way. Its Next row read “Bounce, resistance to hold at 26.04 (VWAP)”.

Over the year before, it had traded between $11.67 and $28.23.

## The release and a 38.2% drop (Wednesday, November 4)

The release crossed at 4:01 PM ET on Tuesday. It opened at $17.16, −33.5%, and the regular session ranged from $14.78 to $17.28 before closing at $15.95. It did this on a day SPY rose 1.7% and XBI, the biotechnology ETF, rose 2.7%.

Into the open the stack read it as bearish (strong) with 5 of 5 higher timeframes down, and Undertow read “volume surge”. Thirty minutes in, the picture had changed: price was below VWAP at $16.20 and the Next row read “Stretched below the averages, bounce area near 15.95”. By the close the 5-minute bias was neutral, while Compass still read “Tailwind down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Thursday, November 5)

It opened at $16.01 (+0.4%) and traded from $14.80 to $16.59, closing at $14.84, −7.0% on 7.1M shares, still 1.9 times its 20-day average. The 5-minute stack bias was bearish (strong), since 12:15 PM: under VWAP 15.72 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “Tailwind down” (15m ↓ 1h ↓ 2h ↓ 4h ↓ D ↓). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.

## The session after (Friday, November 6)

It opened at $15.10 (+1.8%) and traded from $14.79 to $15.52, closing at $15.30, +3.1% on 3M shares, still 0.7 times its 20-day average. The 5-minute stack bias was bearish (weakening), since 2:15 PM: momentum down. Compass read “Tailwind down” (15m ↘ 1h ↘ 2h ↘ 4h ↓ D ↘). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it.

## The session after (Monday, November 9)

It opened at $15.32 (+0.1%) and traded from $15.27 to $16.63, closing at $16.14, +5.5% on 7.6M shares, still 1.9 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “Tailwind down” (15m ↗ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: volume surge, buyers hitting the offer. Tripwire: Longs: Caution, against the daily and weekly cycle.

After hours it last traded at $16.14, with Undertow reading “buyers lead”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 109M | as reported to the SEC |
| Float | 104M | 95% of shares outstanding |
| Last insider sale | November 4, 2026 | 3K shares at $15.38 |

## Sources

- Thu Nov 5, 1:22 PM ET, SEC filing: Amended ownership stake (Schedule 13G/A) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/315066/000031506626002803/xslSCHEDULE_13G_X02/primary_doc.xml
- Thu Nov 5, 7:00 AM ET, Press release: To Present new and updated data from ongoing Phase 1a/1b trial of bexobrutideg (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/05/3396262/0/en/nurix-therapeutics-to-present-new-and-updated-data-from-ongoing-phase-1a-1b-trial-of-bexobrutideg-nx-5948-in-relapsed-refractory-cll-sll-at-the-68th-ash-annual-meeting-and-expositi.html
- Tue Nov 3, 4:02 PM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1549595/000154959526000055/nrix-20261103.htm
- Tue Nov 3, 4:01 PM ET, Press release: Sanofi's decision to discontinue development of STAT6 degrader SAR448272 (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/03/3394742/0/en/nurix-therapeutics-announces-sanofi-s-decision-to-discontinue-development-of-stat6-degrader-sar448272.html

## Questions

### Why did NRIX stock go down on November 4?

Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3, and the stock went from Tuesday’s $25.82 close to as low as $14.78. It finished the session −38.2% at $15.95 on 6.9 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did Nurix Therapeutics announce on November 3, 2026?

Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3.

### How did NRIX stock trade on November 4?

NRIX opened at $17.16, −33.5% from the prior close of $25.82, traded between $14.78 and $17.28 in the regular session and closed at $15.95, −38.2%, on 19.6M shares.

### How did LiveChart’s stack read NRIX at the close on November 4?

At the 4:00 PM ET close the 5-minute stack bias on NRIX was neutral, Compass read “Tailwind down” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on NRIX now?

The read on this page is fixed at each moment it describes. LiveChart reads NRIX on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/NRIX. NRIX catalyst history: https://indicatorstack.com/catalysts/stock/NRIX

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
